Pulse Biosciences, Inc. Forecast, price target & analysts
Pulse Biosciences, Inc. Target price 2026 - Analyst rating & recommendation
Pulse Biosciences, Inc. Classifications & Recommendation
Pulse Biosciences, Inc. Price Target
| Target Price | $44.88 |
| Price | $53.87 |
| Deviation |
16.69%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Pulse Biosciences, Inc. 2027 .
The average Pulse Biosciences, Inc. target price is $44.88.
This is
16.69%
register free of charge
$60.90
13.05%
register free of charge
$35.35
34.38%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Pulse Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Pulse Biosciences, Inc. stock has an average upside potential 2027 of
16.69%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.35 | 2.09 |
| 496.29% | ||
| EBITDA Margin | -20,962.86% | -3,803.41% |
| 81.86% | ||
| Net Margin | -20,794.29% | -4,490.70% |
| 78.40% |
7 Analysts have issued a sales forecast Pulse Biosciences, Inc. 2026 . The average Pulse Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Pulse Biosciences, Inc. EBITDA forecast 2026. The average Pulse Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Pulse Biosciences, Inc. Analysts have issued a net profit forecast 2026. The average Pulse Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.08 | -1.37 |
| 17.39% | 26.85% | |
| P/E | negative | |
| EV/Sales | 1,808.26 |
6 Analysts have issued a Pulse Biosciences, Inc. forecast for earnings per share. The average Pulse Biosciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Pulse Biosciences, Inc....
Current Pulse Biosciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Capital Markets |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 17 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jun 04 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Freedom Capital Markets:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 17 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jun 04 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
